title: Grapefruit-medication interactions.
authors.forename: David J
authors.initials: DJ
authors.lastname: Greenblatt
authors.forename: Hartmut
authors.initials: H
authors.lastname: Derendorf
mesh_terms: D001628:Beverages / Q000009:adverse effects*; D032083:Citrus paradisi / Q000009:adverse effects*; D065692:Cytochrome P-450 CYP3A Inhibitors; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D018565:Food-Drug Interactions / Q000502:physiology*; D005638:Fruit / Q000009:adverse effects*; D006801:Humans; D050216:Metabolic Detoxication, Phase I
chemical_list: D065692:Cytochrome P-450 CYP3A Inhibitors
references.citation: Clin Ther. 1998;20 Suppl C:C40-4
references.pmid: 9915089
references.citation: Expert Opin Drug Metab Toxicol. 2011 Mar;7(3):267-86
references.pmid: 21254874
references.citation: J Gen Intern Med. 2003 Jan;18(1):57-60
references.pmid: 12534765
references.citation: Br Med J (Clin Res Ed). 1982 Jan 23;284(6311):249-52
references.pmid: 6799125
references.citation: J Clin Pharmacol. 2006 Dec;46(12):1390-416
references.pmid: 17101740
references.citation: CMAJ. 2013 Mar 5;185(4):309-16
references.pmid: 23184849
references.citation: Br J Clin Pharmacol. 2011 Sep;72(3):434-41
references.pmid: 21501216